7Baggers

We provide you with 20 years of free, institutional-grade data for QLI stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of QLI. Explore the full financial landscape of QLI stock.

Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
NameActionSharesAvg PriceAmountReported Date
Login to see more insider transactions
The information provided in this report about QLI stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Qilian International Holding Group Limited
(NASDAQ:QLI) 

QLI stock logo

Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs) and traditional Chinese medicine derivative (TCMD) products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant...

CEO: Zhanchang Xin  
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing

Share this website to your friends